PhaseBio Pharmaceuticals, Inc. (PHAS)
Total Liabilities
$139.56M
Quarterly · Period ending: · USD
PHAS Total Liabilities
Latest reported$153.57Mperiod ending
Latest reported$153.57Mperiod ending
PHAS FY Total Liabilities ($91.30M → $153.57M)
Annual total liabilities
High-resolution chart · PNG
PHAS total liabilities history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Liabilities (USD) |
|---|---|
| 153,574,000 | |
| 75,559,000 | |
| 22,516,000 | |
| 12,099,000 | |
| 111,515,000 | |
| 91,299,000 |